What Pharma Companies Can Expect From the Influx of Humira Biosimilars
Drug Channels
OCTOBER 14, 2022
Today’s guest post comes from Steve Callahan, Senior Manager of Market Research at MMIT. Steve walks us through the expected Humira biosimilars launches and discusses potential responses from payers. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Read on for Steve’s insights. d/b/a Drug Channels Institute.
Let's personalize your content